A Study of Palifosfamide Tris Plus Doxorubicin Versus Doxorubicin in Unresectable or Metastatic Soft-tissue Sarcoma - No Study Results Posted

A Study of Palifosfamide Tris Plus Doxorubicin Versus Doxorubicin in Unresectable or Metastatic Soft-tissue Sarcoma (PICASSO)

This study is ongoing, but not recruiting participants.

Study NCT00718484 Information provided by ZIOPHARM

First Received: July 16, 2008 Last Updated: October 15, 2009 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study is ongoing, but not recruiting participants.
Estimated Study Completion Date:	No date given
Estimated Primary Completion Date:	June 2010 (Final data collection date for primary outcome measure)